Home   >  
MAPK Pathway

Classified by application

All Products

Signaling Pathways

Research Areas

Nature products






Raw Materials


Chemical Structure Cat. No. Product Name CAS No.
Donafenib Chemical Structure
BCP34023 Donafenib 1130115-44-4
Donafenib is an oral multikinase inhibitor that targets Raf kinase and receptor tyrosine kinases with potential anticancer acivity. Donafenib is under clinical trials in China in patients with advanced hepatocellular carcinoma (HCC).
AZ304 Chemical Structure
BCP31900 AZ304 942507-42-8
AZ304 is an ATP-competitive dual BRAF kinase inhibitor, potently inhibits wild type BRAF, V600E mutant BRAF and wild type CRAF, with IC50s of 79 nM, 38 nM and 68 nM, respectively. AZ304 also has significant effect on other kinases, such as p38 (IC50, 6 nM), CSF1R (IC50, 35 nM). Anti-tumor activity.
Belvarafenib Chemical Structure
BCP31233 Belvarafenib 1446113-23-0
Belvarafenib is a potent and pan RAF (Rapidly Accelerated Fibrosarcoma) inhibitor, with IC50s of 56 nM, 7 nM and 5 nM for B-RAF, B-RAFv600E and C-RAF respectively.
RO5126766 Chemical Structure
BCP21067 RO5126766 946128-88-7
Ro 5126766 is a first-in-class dual MEK/RAF inhibitor that allosterically inhibits BRAFV600E, CRAF, MEK, and BRAF (IC50: 8.2, 56, 160 nM, and 190 nM, respectively).
LUT-014 Chemical Structure
BCP30636 LUT-014 2274819-46-2
LUT014 is a topical B-Raf Inhibitor, a proprietary, first-in-class, small molecule allowing administration of EGFR (Epidermal Growth Factor Receptor) Inhibitors to patients without interruptions caused by typical cutaneous side effects
LXH254 HCl Chemical Structure
BCP30244 LXH254 HCl LXH254HCl
LXH254 is a potent CRAF inhibitor extracted from patent WO2018051306A1, Compound A. LXH254 also is a potent BRAF inhibitor.
B-Raf inhibitor 1 dihydrochloride Chemical Structure
BCP29713 B-Raf inhibitor 1 dihydrochloride 1191385-19-9
B-Raf inhibitor 1 dihydrochloride is a novel potent and selective B-Raf inhibitor.
Takeda-6d Chemical Structure
BCP29579 Takeda-6d 1125632-93-0
Takeda-6d has potent inhibitory activity in both B-RAF with an IC50 of 7.0 nM and VEGFR2 with an IC50 of 2.2 nM.
PF-04880594 Chemical Structure
BCP21016 PF-04880594 1111636-35-1
PF-04880594 is a RAF inhibitor, which induces ERK phosphorylation and RAF dimerization in those epithelial tissues that undergo hyperplasia.
B-Raf-IN-1 Chemical Structure
BCP28151 B-Raf-IN-1 950736-05-7
B-Raf IN 1 is a highlt potent and selective B-Raf inhibitor with IC50 of 24 nM; equipotent against c-Raf (IC50= 25 nM).
123下一頁末頁共 42 條記錄 1 / 5 頁 
福建36选7奖金 河南22选5最新开奖号码 陕西快乐10分任5奖金 冰球突破大奖 网上真人麻将赌博 时时彩开奖视频 股票玩法 可以提现的棋牌 网上麻将有假吗 湖北省福利彩票大奖在 河北20选5走势图表 泳坛夺金分析技巧 辽宁11选5开奖 短期理财产品 21点扑克游戏网站_点击登陆 怎么看大乐透彩票走势图 快乐扑克三豹子遗漏